Baba H - Search Results

1

Postoperative adjuvant immunochemotherapy and infiltration of dendritic cells for patients with advanced gastric cancer.

Tsujitani S, Kakeji Y, Orita H, Watanabe A, Kohnoe S, Baba H, Anai H, Maehara Y, Sugimachi K. Tsujitani S, et al. Among authors: baba h. Anticancer Res. 1992 May-Jun;12(3):645-8. Anticancer Res. 1992. PMID: 1622120 Clinical Trial.

2

Comparison of R1 and R2 gastrectomy for gastric cancer in patients over 80 years of age.

Korenaga D, Baba H, Kakeji Y, Orita H, Haraguchi M, Maehara Y, Saku M, Sugimachi K. Korenaga D, et al. Among authors: baba h. J Surg Oncol. 1991 Oct;48(2):136-41. doi: 10.1002/jso.2930480213. J Surg Oncol. 1991. PMID: 1921400 Clinical Trial.

3

Surgery for gastric carcinoma is feasible for patients over 80 years of age.

Korenaga D, Moriguchi S, Baba H, Kakeji Y, Orita H, Haraguchi M, Maehara Y, Ueo H, Sugimachi K. Korenaga D, et al. Among authors: baba h. World J Surg. 1991 Sep-Oct;15(5):642-7; discussion 647-8. doi: 10.1007/BF01789215. World J Surg. 1991. PMID: 1949865

4

Prognostic significance of serosal invasion in carcinoma of the stomach.

Haraguchi M, Watanabe A, Kakeji Y, Tsujitani S, Baba H, Maehara Y, Sugimachi K. Haraguchi M, et al. Among authors: baba h. Surg Gynecol Obstet. 1991 Jan;172(1):29-32. Surg Gynecol Obstet. 1991. PMID: 1985338

5

Laser treatment for poor-risk patients with early gastric cancer: post treatment pathology.

Korenaga D, Watanabe A, Saito A, Baba H, Kakeji Y, Maehara Y, Sugimachi K. Korenaga D, et al. Among authors: baba h. Eur J Surg Oncol. 1991 Jun;17(3):316-8. Eur J Surg Oncol. 1991. PMID: 2044788

6

Clinicopathologic features and prognostic significance of duodenal invasion in patients with distal gastric carcinoma.

Kakeji Y, Tsujitani S, Baba H, Moriguchi S, Mori M, Maehara Y, Kamegawa T, Sugimachi K. Kakeji Y, et al. Among authors: baba h. Cancer. 1991 Jul 15;68(2):380-4. doi: 10.1002/1097-0142(19910715)68:2<380::aid-cncr2820680228>3.0.co;2-a. Cancer. 1991. PMID: 2070336

7

Postgastrectomy prescription of mitomycin C and UFT for patients with stage IV gastric carcinoma.

Maehara Y, Watanabe A, Kakeji Y, Baba H, Kohnoe S, Sugimachi K. Maehara Y, et al. Among authors: baba h. Am J Surg. 1990 Sep;160(3):242-4. doi: 10.1016/s0002-9610(06)80015-2. Am J Surg. 1990. PMID: 2118308 No abstract available.

8

Adjuvant mitomycin-C prolongs survival time of patients undergoing extensive en bloc resection of carcinoma of the stomach invading the adjacent organs.

Korenaga D, Baba H, Watanabe A, Haraguchi M, Kakeji Y, Orita H, Maehara Y, Sugimachi K. Korenaga D, et al. Among authors: baba h. Pharmacology. 1990;41(2):107-12. doi: 10.1159/000138705. Pharmacology. 1990. PMID: 2124713

9

Postoperative adjuvant chemotherapy inhibits early recurrence of early gastric carcinoma.

Okamura T, Korenaga D, Baba H, Saito A, Sugimachi K. Okamura T, et al. Among authors: baba h. Cancer Chemother Pharmacol. 1989;23(5):319-22. doi: 10.1007/BF00292412. Cancer Chemother Pharmacol. 1989. PMID: 2495863

10

Surgical treatment of patients with gastric carcinoma and duodenal invasion.

Kakeji Y, Korenaga D, Baba H, Watanabe A, Tsujitani S, Maehara Y, Sugimachi K. Kakeji Y, et al. Among authors: baba h. J Surg Oncol. 1995 Aug;59(4):215-9. doi: 10.1002/jso.2930590403. J Surg Oncol. 1995. PMID: 7630166

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,313 results

Search Page

Filters